Clinical Trials Directory

Trials / Sponsors / Jennerex Biotherapeutics

Jennerex Biotherapeutics

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver Cancer
Hepatocellular Carinoma
Phase 22012-06-01
CompletedRecombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carci
Colorectal Carcinoma, CRC
Phase 1 / Phase 22012-01-01
TerminatedNeoadjuvant Study of Recombinant Vaccinia Virus to Treat Metastatic Colorectal Carcinoma in Patients Undergoin
Colorectal Carcinoma
Phase 22011-10-01
CompletedSafety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients
Neuroblastoma, Rhabdomyosarcoma, Lymphoma
Phase 12010-08-01
CompletedSafety Study of Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory
Carcinoma, Colorectal
Phase 12010-07-01
CompletedA Study of Recombinant Vaccinia Virus Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinom
Carcinoma, Hepatocellular
Phase 22009-08-01
CompletedA Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib
Hepatocellular Carcinoma, Liver Cancer, HCC
Phase 22008-12-01
CompletedA Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma
Carcinoma, Hepatocellular
Phase 22008-08-01
CompletedSafety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors
Melanoma, Lung Cancer, Renal Cell Carcinoma
Phase 12008-06-01
CompletedA Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma
Melanoma
Phase 1 / Phase 22007-03-01
CompletedA Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within th
Neoplasms, Liver
Phase 12006-01-01